< Back to latest news & events

Event

IAM webinar: How to capitalise on the 5G healthcare revolution

April 2021

Event date: 25th May 2021

HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May.

This session will explore how 5G wireless technology will revolutionise the healthcare industry. 5G is promising greater bandwidth, faster speeds and lower latency, and with that, to transform industries including healthcare. Virtual patient care, remote robotic surgery and sharing of 3D medical images for diagnosis of specialists located anywhere across the globe are a few examples of transformative changes to come. 5G will not only enable new healthcare services but also improve the workflow of hospitals and healthcare professionals as they evolve from using wired networks to mobile networks. 5G is also considered to expand the wearables market further as wearables will be able to send and receive far greater amounts of data wirelessly than with 4G, providing the wearers and doctors with real-time monitoring data in volumes that will allow much more powerful insight into an individual’s health status. This session will also explore challenges of 5G in the healthcare industry including how to recognise patentable aspects of 5G implementation in the healthcare sector, data security aspects, and how patent owners of 5G technology can license patents for their technology in vertical markets such as wearables.

Join Dr Susan Keston and Dr Sofie McPherson to find out more on this topic on Tuesday 25th May 2021.

Latest updates

The FoodTech Series #1 | Medicament, functional food, nutritive product in the same claim 1: when your own examples no longer support the “improvement”

            The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they ruled on an opposition …

Read article

A New Era for AI Patents in the UK: Supreme Court Aligns with the EPO

The UK Supreme Court has handed down its long-awaited judgment in Emotional Perception AI Limited (EPAI) vs Comptroller General of Patents, a decision which serves to significantly change the way …

Read article
Event - 23rd - 25th March 2026

HGF are Gold Sponsors of IPBC Europe 2026

HGF are proud sponsors of IPBC Europe 2026, taking place from 23-25 March 2026 at the Pullman Paris Montparnasse. Bringing together patent pioneers, in-house leaders and private practice specialists, IPBC …

Event details
Event - 8th - 11th February 2026

AUTM Meeting 2026

We are attending the AUTM Annual Meeting from 8–11 February, a flagship event bringing together technology transfer professionals from across the globe. AUTM connects innovators, universities, and industry leaders to …

Event details

The Antibody Series #5 | Epitope-defined antibody claims: when “binds to this epitope” becomes a risk of insufficiency

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews decisions made at the EPO; here, they reviewed an appeal in opposition proceedings after the revocation …

Read article

The Deity Shoes case: a question of design activity and the constraints on a designer’s freedom

The footwear brand Deity Shoes sought to enforce their Community Design rights, both registered and unregistered, against Mundorama Confort and Stay Design. However, Mundorama Confort and Stay Design found fault …

Read article

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article

The Antibody Series #3 | Antibody code names in claims: why “ACZ885” is not sufficient to define the antibody

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions. In this case, they examined a claim that identified an antibody by an internal …

Read article